WHO ICTRP trial
Study to assess the effectiveness of high doses of immunoglobulin in the…
EUCTR2010-023883-42-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-023883-42-IT |
|---|---|
| Public title | Study to assess the effectiveness of high doses of immunoglobulin in the treatment of polyneuropathy painful diabetic resistant to conventional therapies |
| Scientific title | Randomized, double-blind, placebo controlled trial to evaluate the efficacy of high dose intravenous immunoglobulins in diabetic painful polyneuropaty (DPNP)resistant to conventional therapies - IGD002 |
| Primary sponsor | AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | painful diabetic polyneuropathy resistant to conventional therapies MedDRA version: 14.1 Level: SOC Classification code 10029205 Term: Nervous system disorders System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area… |
| Interventions | Trade Name: FLEBOGAMMA DIF Pharmaceutical Form: Solution for infusion INN or Proposed INN: HUMAN NORMAL IMMUNOGLOBULIN CAS Number: NA Current Sponsor code: NA Other descriptive name: NA Concentration unit: mg milligram(s) Concentration… |
| Registration date | Aug 3, 2012 |
| Secondary IDs | IGD002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: